What Researchers Did
Researchers conducted a randomized, placebo-controlled trial to investigate if hyperbaric oxygen therapy could help adults with jaw bone damage caused by radiation treatment.
What They Found
After one year, 19% (6 of 31) of patients receiving hyperbaric oxygen therapy recovered, compared to 32% (12 of 37) in the placebo group. The study found no significant difference in recovery rates, time to treatment failure, or time to pain relief between the two groups. The researchers concluded that patients with overt mandibular osteoradionecrosis did not benefit from hyperbaric oxygenation.
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy may not be an effective treatment for overt mandibular osteoradionecrosis. Canadian patients with this condition should discuss these findings with their healthcare providers when considering treatment options. Further research may be needed to explore other potential benefits or specific patient subgroups.
Canadian Relevance
This study investigates osteoradionecrosis, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
The study was stopped early due to potentially worse outcomes observed in the hyperbaric oxygen therapy group, which could impact the full scope of the findings.